Annals ofMultiple Sclerosis

Volume: 4 - Number: 27 - December 15, 2007

Outstanding

Molecular Mimicry Revisited: Gut Bacteria and Multiple Sclerosis.

Role of MRI in diagnosing multiple sclerosis Early diagnosis using MRI and early treatment delays disease conversion

Lessons for clinical trials from natalizumab in multiple sclerosis

Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.

Investigational Article

Molecular Mimicry Revisited: Gut Bacteria and Multiple Sclerosis.

Role of MRI in diagnosing multiple sclerosis Early diagnosis using MRI and early treatment delays disease conversion

Role of MRI in diagnosing multiple sclerosis Magnetic resonance imaging is valuable

Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review

Gray matter MRI T2 hypointensity predicts longitudinal brain atrophy in multiple sclerosis

Multiple sclerosis may disrupt endocannabinoid brain protection mechanism

Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2R?-targeted therapy (daclizumab) in multiple sclerosis

Therapeutic Effect of Vasoactive Intestinal Peptide on Experimental Autoimmune Encephalomyelitis : Down-Regulation of Inflammatory and Autoimmune Responses.

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection

Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease.

Diagnosis and treatment of multiple sclerosis: Ocular manifestations of multiple sclerosis

Diagnosis and treatment of multiple sclerosis

CD4+ regulatory T cell responses induced by T cell vaccination in patients with multiple sclerosis

Diagnosis and treatment of multiple sclerosis

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.

Genetic variation in the myeloperoxidase gene and cognitive impairment in Multiple Sclerosis

Gene expression profiles in Finnish twins with multiple sclerosis

Lessons for clinical trials from natalizumab in multiple sclerosis

Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5

Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.

Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis.

Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.